Hattori N, Kato Y, Murakami Y, Koshiyama H, Inoue T, Imura H
Department of Medicine, Kyoto University Faculty of Medicine, Japan.
Nihon Naibunpi Gakkai Zasshi. 1988 Feb 20;64(2):78-92. doi: 10.1507/endocrine1927.64.2_78.
A highly sensitive enzyme immunoassay (EIA) for measurement of urine hGH was set up by a modification of the method of Hashida and Ishikawa, which was a sandwich enzyme immunoassay using anti-hGH antibody coated polystyrene balls and anti-hGH antibody-peroxidase conjugate. Anti-hGH serum was obtained in rabbits by subcutaneous injections of hGH emulsified in complete Freund's adjuvant. In order to reduce non-specific binding to the solid phase, anti-hGH IgG was precipitated from rabbit serum followed by digestion to F(ab')2 and affinity purification. Fab'-peroxidase conjugate was produced by maleimide method. The assay procedure was as follows. 1. 100 microliters of urine samples or hGH standard were incubated with anti-hGH IgG coated polystyrene balls. 2. Polystyrene balls were then incubated with Fab'-peroxidase conjugate. Polystyrene balls were carefully washed three times in saline after incubation with Fab'-peroxidase conjugate, which reduced contamination and non-specific binding. 3. Peroxidase activity bound to the balls was assayed by enzyme reaction using 3(p-hydroxyphenyl) propionic acid as a substrate, and fluorescence intensity was measured by a spectrofluorophotometer (Shimadzu RF-540). Reducing the energy of excitation by setting the slit width of the spectrofluorophotometer at 2nm made it possible to gain stable fluorescence. The minimum detectable quantity of hGH was 30fg/tube in the assay, so that the detection limit was 0.3 pg/ml when 100 microliters of urine samples were used. Coefficient of intra- and inter-assay variation was 6.0% and 8.6%, respectively. The recovery was 98.8 +/- 2.8 (+/- SE) on average. Multiple dilution of acromegalic urine and urine after insulin injection produced dose-response curves parallel to those of the standards. Urine hGH levels in acromegalic patients were significantly greater than those in normal subjects. These findings indicate that sensitive EIA of urine hGH is potentially useful for evaluating the pituitary function.
通过对桥田和石川的方法进行改进,建立了一种用于测量尿中人生长激素(hGH)的高灵敏度酶免疫分析(EIA)方法,该方法是一种夹心酶免疫分析,使用包被抗hGH抗体的聚苯乙烯球和抗hGH抗体-过氧化物酶偶联物。通过皮下注射完全弗氏佐剂乳化的hGH,在兔体内获得抗hGH血清。为了减少与固相的非特异性结合,从兔血清中沉淀抗hGH IgG,然后消化成F(ab')2并进行亲和纯化。通过马来酰亚胺法制备Fab'-过氧化物酶偶联物。测定步骤如下。1. 将100微升尿样或hGH标准品与包被抗hGH IgG的聚苯乙烯球孵育。2. 然后将聚苯乙烯球与Fab'-过氧化物酶偶联物孵育。与Fab'-过氧化物酶偶联物孵育后,将聚苯乙烯球在盐水中小心洗涤三次,这减少了污染和非特异性结合。3. 通过以3(对羟基苯基)丙酸为底物的酶反应测定结合在球上的过氧化物酶活性,并使用荧光分光光度计(岛津RF-540)测量荧光强度。通过将荧光分光光度计的狭缝宽度设置为2nm来降低激发能量,从而获得稳定的荧光。该测定中hGH的最低检测量为30fg/管,因此当使用100微升尿样时,检测限为0.3 pg/ml。批内和批间变异系数分别为6.0%和8.6%。平均回收率为98.8±2.8(±标准误)。肢端肥大症患者尿液和胰岛素注射后尿液的多次稀释产生了与标准品平行的剂量反应曲线。肢端肥大症患者的尿hGH水平显著高于正常受试者。这些发现表明,尿hGH的灵敏EIA在评估垂体功能方面可能有用。